Skip to content

Weight loss10 minute read

Sleep apnoea and weight loss: what helps and what to expect

Written by Docalo editorial teamPublished 2 October 2026Updated

Obstructive sleep apnoea is closely linked with weight. Here is how it is diagnosed and treated, what weight loss can change, what recent trials show and why drowsy driving matters.

A made bed with a crumpled pillow, a glass of water and a lamp on the bedside table, pale dawn light at the window.
Share:

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Doctor reply in under 2 hours

Average doctor reply under 2 hours; prescription within 24 hours if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

Key takeaways - Obstructive sleep apnoea (OSA) means the airway repeatedly narrows or closes during sleep. Loud snoring, gasping at night and daytime sleepiness are common signs. - Weight is one of the strongest risk factors: in a long-term cohort study, a 10% change in weight was linked with a roughly 26-32% change in apnoea severity. - CPAP remains the main treatment for moderate and severe OSA. Weight loss can reduce severity but does not replace a proper sleep assessment. - If you feel sleepy while driving, stop driving and speak to a doctor. Untreated OSA increases the risk of road accidents.

Docalo pairs you with a licensed doctor who reviews your health and builds a weight plan with you.

Start your assessment

If your partner says you snore loudly or stop breathing at night, or if you wake up unrefreshed and fight sleep during the day, obstructive sleep apnoea is worth considering. It is common, often undiagnosed, and closely linked with weight.

This guide explains what OSA is, how it is diagnosed and treated, how much weight loss can help, what recent trials of weight-loss medicine found, and why sleepiness at the wheel needs urgent attention.

What obstructive sleep apnoea is

During sleep, the muscles in the throat relax. In OSA, the airway narrows (a hypopnoea) or closes completely (an apnoea) again and again. Breathing becomes shallow or stops for 10 seconds or more, oxygen levels fall, and the brain briefly wakes you to reopen the airway. Most people do not remember these awakenings, but they break up deep sleep.

Severity is usually measured with the apnoea-hypopnoea index (AHI): the average number of these events per hour of sleep.

AHI (events per hour)SeverityWhat it usually means
Fewer than 5NormalNo sleep apnoea
5-14MildTreatment depends on symptoms
15-29ModerateCPAP usually recommended
30 or moreSevereCPAP usually recommended

Common symptoms

  • loud, regular snoring
  • pauses in breathing, choking or gasping noticed by a partner
  • waking unrefreshed, often with a dry mouth or headache
  • feeling very sleepy during the day, or falling asleep when you do not mean to
  • poor concentration, irritability or low mood
  • needing to pass urine often at night

Not everyone with OSA snores loudly or feels sleepy, and not everyone who snores has OSA. That is why a proper assessment matters.

Why weight and sleep apnoea are linked

Fat stored around the neck, tongue and upper airway narrows the space for air and makes the airway more likely to collapse. Fat around the abdomen reduces lung volume, which also makes the airway less stable. Other factors include age, being male, the shape of the jaw, large tonsils, alcohol and sedating medicines, and the menopause.

The link works in both directions. OSA fragments sleep, and poor sleep affects appetite. In a laboratory study of sleep restriction, two nights of short sleep in 12 healthy young men lowered the fullness hormone leptin and raised the hunger hormone ghrelin, and participants reported feeling hungrier. Tiredness also makes it harder to be active. Our article on sleep and appetite explains more.

How OSA is diagnosed and treated

Assessment

The NICE guideline on obstructive sleep apnoea recommends that doctors use the Epworth Sleepiness Scale, and consider the STOP-Bang questionnaire, when assessing suspected OSA, and refer people with suspected OSA to a sleep service. Diagnosis is usually made with a sleep study, often done at home with a small monitor that records breathing, oxygen levels and heart rate overnight.

Treatment

  • CPAP (continuous positive airway pressure). A small machine blows air through a mask to keep the airway open. NICE recommends it for moderate and severe OSA, and it can be considered for mild OSA when symptoms affect daily life. It works well when it is used regularly, although many people need time and support to get used to it.
  • Mandibular advancement splints. A dental device worn at night that moves the lower jaw forward. NICE suggests it as an alternative for people who cannot tolerate CPAP or prefer not to try it.
  • Lifestyle changes. Losing weight if you live with overweight or obesity, cutting back on alcohol, stopping smoking and avoiding sleeping on your back can all help.

What weight loss can change

Evidence from long-term studies

In the Wisconsin Sleep Cohort study, researchers followed 690 adults for four years. On average, a 10% weight gain was linked with about a 32% rise in AHI, and a 10% weight loss with about a 26% fall. A 10% weight gain was also linked with around a sixfold higher chance of developing moderate or severe sleep-disordered breathing.

These are associations from an observational study, not proof that weight loss will have the same effect for everyone. The anatomy of your airway matters a lot. Some people see a big improvement with moderate weight loss, others very little.

Evidence from SURMOUNT-OSA

The SURMOUNT-OSA trials tested a once-weekly dual GIP/GLP-1 medicine in adults with obesity and moderate to severe OSA. There were two trials over 52 weeks: one in people not using CPAP and one in people who continued CPAP.

On average, participants on the medicine lost around 18-20% of their body weight. Their AHI fell by about 25 events per hour in the trial without CPAP and about 29 events per hour in the trial with CPAP, compared with about 5 events per hour in the placebo groups.

Important caveats:

  • these are averages, and individual results varied widely;
  • many participants still had some degree of sleep apnoea at the end of the trials;
  • the trials lasted one year, and benefits depend on continuing treatment, since weight usually returns when it stops;
  • side effects, mostly nausea, diarrhoea and other digestive symptoms, were common;
  • the trials were funded by the manufacturer.

Weight-loss medicine is not a replacement for CPAP. If you use CPAP, keep using it and talk to your sleep team before changing anything.

Realistic expectations

Even modest weight loss can make CPAP more comfortable, reduce snoring and improve energy. Our guide to realistic weight-loss goals explains why smaller sustained losses still count. You can check where you are starting from with the BMI calculator, keeping in mind that BMI is only a rough measure and neck and waist size also matter for OSA.

Sleepiness and driving

Untreated OSA makes people more likely to have road accidents, because sleepiness can lead to brief lapses in attention or "micro-sleeps" without warning.

  • If you feel sleepy while driving, do not drive. Stop somewhere safe and rest.
  • If you think you might have OSA and you often feel sleepy during the day, speak to a doctor promptly.
  • Rules on telling your driving licence authority about sleep apnoea differ between countries and often depend on how sleepy you are. Ask your doctor what applies to you, especially if you drive for work.
  • Most people can keep driving safely once their OSA is treated and sleepiness is under control.

Why treatment matters beyond sleep

Untreated moderate or severe OSA is linked with high blood pressure, heart rhythm problems, type 2 diabetes and low mood. Treating it can improve energy, concentration and quality of life, and it may help with blood pressure in some people. Our article on blood pressure and weight loss covers that link.

When medical weight management fits

The NICE guideline on overweight and obesity supports a stepped approach for people living with overweight or obesity, with medicines considered for some people depending on BMI and related conditions such as sleep apnoea. If clinically appropriate, a doctor may prescribe a weight-loss medicine as part of a wider plan, alongside the treatment your sleep team recommends.

How Docalo can help

Docalo is an online medical service focused only on weight loss. Your €49/month membership covers a doctor consultation, a personal plan and follow-up with the medical team. Docalo does not diagnose sleep apnoea or provide CPAP, so sleep studies and CPAP stay with your usual doctor or sleep clinic.

A licensed doctor reviews your health questionnaire and decides whether treatment is appropriate for you. If they prescribe medication, it is paid separately at the pharmacy. If sleep apnoea is part of your health picture and you want support with weight, you can start your consultation.

One Docalo membership covers the doctor assessment, a personal plan, monthly follow-up and messaging. Medication, if prescribed, is paid separately at the pharmacy.

Start your assessment

COMMON QUESTIONS

Frequently asked questions

For some people, weight loss reduces sleep apnoea a lot, and occasionally to the point where treatment is no longer needed. For others, the shape of the airway matters more and improvement is smaller. A repeat sleep assessment is the only way to know, so do not stop CPAP without speaking to your sleep team.

References

  1. NICE guideline NG202: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s. 2021.
  2. Peppard PE et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21.
  3. Malhotra A et al. The SURMOUNT-OSA trials. N Engl J Med 2024;391:1193-1205.
  4. Spiegel K et al. Sleep curtailment is associated with decreased leptin, elevated ghrelin and increased hunger. Ann Intern Med 2004;141:846-50.
  5. NICE guideline NG246: Overweight and obesity management. 2025.

Own your health

New guides and Docalo news. At most two emails a month.